Search by Drug Name or NDC
NDC 00115-5212-29 COLESTIPOL HYDROCHLORIDE 5 g/1 Details
COLESTIPOL HYDROCHLORIDE 5 g/1
COLESTIPOL HYDROCHLORIDE is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is COLESTIPOL HYDROCHLORIDE.
Product Information
| NDC | 00115-5212 |
|---|---|
| Product ID | 0115-5212_78f0e0f5-e61e-4c11-8e35-b65bcdfcfc06 |
| Associated GPIs | 39100020103010 |
| GCN Sequence Number | 003102 |
| GCN Sequence Number Description | colestipol HCl PACKET 5 G ORAL |
| HIC3 | D7L |
| HIC3 Description | BILE SALT SEQUESTRANTS |
| GCN | 25440 |
| HICL Sequence Number | 001374 |
| HICL Sequence Number Description | COLESTIPOL HCL |
| Brand/Generic | Generic |
| Proprietary Name | COLESTIPOL HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | COLESTIPOL HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | g/1 |
| Substance Name | COLESTIPOL HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals of New York LLC |
| Pharmaceutical Class | Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077277 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00115-5212-29 (00115521229)
| NDC Package Code | 0115-5212-29 |
|---|---|
| Billing NDC | 00115521229 |
| Package | 90 SUSPENSION in 1 CARTON (0115-5212-29) |
| Marketing Start Date | 2006-05-02 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.71783 |
| Pricing Unit | EA |
| Effective Date | 2022-10-19 |
| NDC Description | COLESTIPOL HCL GRANULES PACKET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis